about
Therapeutic cancer vaccines and combination immunotherapies involving vaccinationThe Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.A blast without power - cell death induced by the tuberculosis-necrotizing toxin fails to elicit adequate immune responses.Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment.NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27New insights into IL-12-mediated tumor suppression.The antitumor potential of Interleukin-27 in prostate cancer.The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy.Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer.Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth.Immune Regulation of Interleukin-27 in Malignant Pleural EffusionInterleukin-27 rs153109 polymorphism and the risk of non-small-cell lung cancer in a Chinese population.IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs.Xiao-Ai-Ping, a TCM Injection, Enhances the Antigrowth Effects of Cisplatin on Lewis Lung Cancer Cells through Promoting the Infiltration and Function of CD8(+) T Lymphocytes.The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte responseIL-27 Directly Enhances Germinal Center B Cell Activity and Potentiates Lupus in Sanroque Mice.Administration of DNA Encoding the Interleukin-27 Gene Augments Antitumour Responses through Non-adaptive Immunity.Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses.Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27-Stimulated Cytotoxicity of NK Cells.Significantly mutated genes and regulatory pathways in SCLC-a meta-analysis.Recombinant protein rMBP-NAP restricts tumor progression by triggering antitumor immunity in mouse metastatic lung cancer.The effect of royal jelly on the growth of breast cancer in mice.Association between polymorphisms in IL27 gene and renal cell carcinoma.Association between polymorphisms in IL27 and risk for CHD in a Chinese population.
P2860
Q28397609-C176A4E9-5C81-4DDD-9420-97A28609A142Q30486741-954D6EFE-2849-4714-ACA3-05085695FB57Q30799863-2874059F-BE20-4D81-AA72-A2960E4630A2Q33715943-909D24B8-CDCA-4EB8-A9E7-F96E751CF493Q33798745-5DAF7838-0997-46CA-8C51-6F8370B8C774Q34436897-F66E7D86-62E8-42C9-BE22-64E3E9026FEBQ34786440-15D23E05-9553-4665-867D-DB5C2FDDB1F4Q35166971-7C965734-37B7-4356-A9EA-7D52F64CEB6BQ35551845-6329B0AB-D6B8-4D56-A5DA-ADB4CBE78DB1Q35654119-79E8BB44-9373-4AF5-89B0-BDED34287A26Q35799014-1754890B-DFB1-421B-8CEC-52F3B6936BA2Q36477134-AE0D8252-1610-4C38-967C-1DA89F09AC26Q36627497-8B6F017D-088B-42BA-BE0F-B7F25566192EQ36861764-F9245F2A-B19C-4300-8DAB-DE734EC8351AQ37061399-67681F2A-81CA-40C9-99B5-619D9126D7D7Q37099883-391F1A4A-7760-459D-A824-9B60B383A5BCQ39399282-F5253248-945D-4543-978B-78EBC634B55FQ40814716-0B8B2058-2C33-41A3-BEDF-F520FE222631Q41918691-68D11E2F-5C95-4007-BABB-E58F40E967B7Q47159069-7E9F95CC-BF28-437C-BDAC-2275938BD80AQ47660753-A91F11A1-9DD1-44A3-8AEE-305D5DC65DB1Q47869837-58DCFE09-136D-46DA-9DDB-E2B1FA0AFE96Q49839312-E8BA5CED-42AB-4D32-AC12-4A8FF33CB622Q53216723-5D8AEB86-6598-4572-AD5B-6DC547CD9AEEQ54174885-3FB46B16-7C46-492C-8C5A-692EC0A61859
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
IL-27 in tumor immunity and immunotherapy.
@en
type
label
IL-27 in tumor immunity and immunotherapy.
@en
prefLabel
IL-27 in tumor immunity and immunotherapy.
@en
P1476
IL-27 in tumor immunity and immunotherapy.
@en
P2093
Bhaskar Saha
Gopal Murugaiyan
P304
P356
10.1016/J.MOLMED.2012.12.002
P577
2013-01-07T00:00:00Z